Sofgen Pharma SAPROCF
13F holders, Q1 2024 (March 31)9holders
2famous investors
$3.01avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Sofgen Pharma SA (PROCF) in their 13F filings. The largest holders were Geode Capital Management, LLC ($89K), Renaissance Technologies ($73K) and Citadel Advisors ($39K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sofgen Pharma SA
- Filed as
- PROCAPS GROUP SA (Q1 2024)
- CUSIP
- L7756P102
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $112K |
| Exits | 4 | $668K |
Ownership 9 holders
| Geode Capital Management, LLC | 0.00% | Add +14.0% | 28,938 | $89K |
| Renaissance Technologies | 0.00% | New | 25,300 | $73K |
| Citadel Advisors | 0.00% | New | 12,500 | $39K |
| State Street Corp. | 0.00% | Add +1.0% | 12,363 | $38K |
| Activest Wealth Management | 0.01% | No change | 10,000 | $29K |
| Royal Bank of Canada | 0.00% | Add +76.6% | 362 | $1K |
| Pineridge Advisors LLC | 0.00% | No change | 250 | $725 |
| Morgan Stanley | 0.00% | No change | 100 | $290 |
| UBS Group AG | 0.00% | Reduce -99.9% | 42 | $122 |
"% of holder's portfolio" is PROCF's weight in each manager's 13F, not the share of Sofgen Pharma SA the manager owns.